Biomed Realty Trust (NYSE: BMR) reported Q2 FFO of $0.58, $0.09 better than the analyst estimate of $0.49. Revenue for the quarter came in at $157.97 million versus the consensus estimate of $158.69 million.

Biomed Realty Trust sees FY2015 FFO of $1.75 - $1.81, versus the consensus of $1.59.

For earnings history and earnings-related data on Biomed Realty Trust (BMR) click here.